Literature DB >> 34425232

Development of agomelatine nanocomposite formulations by wet media milling.

Elisavet Vardaka1, Ouranidis Andreas2, Ioannis Nikolakakis1, Kyriakos Kachrimanis3.   

Abstract

Nanocrystal formulations of the BCS class II agomelatine, were developed by wet media milling. The most suitable stabilizer was identified and effects of process and formulation variables on the nanocrystal size and ζ-potential were evaluated employing a Box-Behnken experimental design. The optimized nanosuspensions were dried and subsequently evaluated for redispersibility and physicochemical properties. Computational simulation of solid state properties was applied to rationalize crystal fracture. It was found that low viscosity hydroxypropylcellulose with sodium dodecyl sulfate is the most suitable stabilizer. Stabilizer concentration exerts a statistically significant effect on particle size, which depends on the mill's rotation speed. The milling process induces a polymorphic transition to form II, which could affect size reduction kinetics. The solidified nanosuspensions' redispersibility is deteriorating progressively with storage time, with only minor differences between drying methods, retaining enhanced dissolution rate. Crystal lattice simulations suggest high mechanical anisotropy of form I crystals, which could be an additional reason for fast particle size reduction prior to the polymorphic transformation. Wet media milling, combined with a suitable drying method, can be an efficient technique for the production of stable nanocrystals of agomelatine. Particle informatics methods can enhance our understanding of the mechanisms responsible for agomelatine's nanocomminution.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Agomelatine; Dissolution; Nanocrystals; Nanosuspension stabilizer; Particle informatics; Wet media milling

Mesh:

Substances:

Year:  2021        PMID: 34425232     DOI: 10.1016/j.ejps.2021.105979

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  1 in total

1.  Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected Pair.

Authors:  Michele Schlich; Luca Casula; Aurora Musa; Rosa Pireddu; Giulia Pitzanti; Maria Cristina Cardia; Donatella Valenti; Salvatore Marceddu; Anna Maria Fadda; Maria Antonietta De Luca; Chiara Sinico; Francesco Lai
Journal:  Pharmaceutics       Date:  2022-05-19       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.